The Valley Desk

NCT00715637 · Interventional trial

Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study

Overall registry status Unknown

Phase 3

Conditions Secondary Acute Myeloid Leukemia (Secondary AML, sAML)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov